CUAMC
GRCL

China Universal Asset Management Company’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

China Universal Asset Management Company’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$84.4K Buy
2023
Q3 		$5.03K Buy
2023
Q2 		$3.4K Sell
2023
Q1 		$1.68K Buy
2022
Q4 		$1.56K Buy
2022
Q3 		$2K Buy